PROGRAM

SUMMIT VENUEWCROOM - A
Plenary Hall

EV
WC

Parking

ROOM - B2

Event Hall

SubwayExit 4-2

RiverGrand Prince
Hotel
Kyoto

Entrance

Annex Hall

Entrance

1F

GroundFloor

Kyoto University

Kyoto
International
Conference Center(ICCK)

Pond
GardenEV

ROOM - B1

2F
EV

003

004

PROGRAMPROGRAMMONDAY, APRIL 13
Grand Prince Hotel Kyoto
9:30

Registration opens

10:30 - 11:15

Opening Ceremony

TUESDAY, APRIL 14
The venue for the session in a.m. is "Grand Prince Hotel Kyoto" (2 min walk from ICCK).

Kyoto International Conference Center (ICCK)ROOM - A (Plenary Hall)ROOM - B1

ROOM - B2

Poster Session

Michael J. Klag
Johns Hopkins Bloomberg
School of Public Health

10:00 - 11:30

Keynote Speech
Barry R. Bloom
Harvard School of Public Health

12:00 - 12:45
12:00 - 13:00

Kyoto International Conference Center (ICCK)ROOM - B1

Keynote Speech

13:15 - 14:00
ROOM - B2

PUBLIC SPACE

14:15 - 15:45

Symposium

Panel Discussion

Global Health R&D

Primary Care

16:00 - 16:45
16:00 - 16:45

Panel Discussion

Health Technology
Assessment

Fostering New Leadershipin Medical Academia

Special Lecture (with lunch)

Keynote Speech
Ichiro Kawachi
Harvard Schoolof Public Health

Poster ExhibitionPeter Piot
London School of Hygiene
and Tropical Medicine

14:15 - 15:45

Panel Discussion

Sport Events andSport for All

Symposium

Panel Discussion

Social Connectednessand Healthy Aging

Building a Resilient
Healthcare System- Lessons Learned
from Fukushima

Special Lecture
Masayo Takahashi
RIKEN

Keynote Speech
John Z. Ayanian
University of Michigan

17:00 - 18:00
17:00 - 18:30

19:00 - 20:30

Symposium

Panel Discussion

Designing a Healthy CityBig Data in Healthcare

TUESDAY
APRIL 14MONDAYAPRIL 13

13:15 - 14:00

Symposium

Yoshiyuki Sankai
University of Tsukuba

Lunch Break

ROOM - A (Plenary Hall)

PUBLIC SPACE
Poster Exhibition

9:00 - 10:00

11:15 - 12:00

Closing Ceremony
Best Poster Award
Ugur ErdenerIOC
Hiroo Imura
Kyoto University

Social Event
Welcome Reception(Venue : SWAN)

005

Special Lecture

Keynote Speech

Symposium

Panel Discussion

Poster Exhibition

TABLE OF CONTENTS

006

Summit Venue
Program
Table of Contents
Welcome Messages
Participants and Key Facts
Track Information
Vision, Mission, Goals
WHS Presidents and Council
M8 Alliance
Summit Program : Monday, April 13, 2015 in English
Summit Program : Tuesday, April 14, 2015 in English
Summit Program : Monday, April 13, 2015 in Japanease
Summit Program : Tuesday, April 14, 2015 in Japanease
General Information and Maps
Summit Venue
Public Transport
About the Host City
Sights of Kyoto
About Kyoto University
About Kyoto University SPH
About Fukushima Medical University
Partners
Speaker Index

Photo byⒸTomo.Yun

http://www.yunphoto.net

Ryoan-ji Temple

007

008

WELCOME MESSAGE

WELCOME MESSAGE

Dear Friends, Dear Colleagues,
Welcome to Kyoto! We are honored
to host the “World Health Summit
Regional Meeting Asia, Kyoto 2015”.
Since its foundation in 1897, Kyoto
University has opened up newhorizons in creative scholarly
endeavors. The university has alsosought to contribute to peacefulcoexistence across the global
community.
Modern medicine in Japan was
founded mainly based on German
medicine which was imported about
150 years ago. At that time, infectious
diseases were the greatest threat to
mankind and, naturally, the leading
field of medicine was microbiology
and pathology. However, it is naturalthat medicine never ends in thelaboratory. Physicians have to face
their patients considering social andfamilial backgrounds as well as
medical conditions. It is also very
important to implement health policy
based on evidence from the
population. Collaborations between
clinical medicine and public healthare the most important to resolve
health problems in societies.

Dear Friends, Dear Colleagues,
Having the longest life expectancy inthe world and burgeoning elderly
population, Japan has transitioned toan aging society well before mostother countries. Soon enough, it islikely that developing as well as otherindustrialized countries will facesimilar demographic changes. Thus, it
is our responsibility to summarize, at
this WHS Regional Meeting, ourefforts directed toward transformingof healthcare systems in preparation
for a rapidly aging society.

It is a great honor to co-host thisWorld Health Summit Regional
Meeting together with Kyoto
University.

At this landmark conference, we lookforward to sharing our thoughts in
the hope of promoting rewarding
discussions among leaders in theirrespective fields of expertise.

After the Great East Japan
Earthquake in 2011, over 16,000
people in Fukushima are still forced
to live as evacuees as a result of thenuclear disaster, and 50,000 people
have moved out of the prefecture.
Within the first year after theevacuation, there were twice as many
deaths among elderly people inspecial care facilities as in an average
year.

Nagahiro Minato
Executive Director, Vice-President
Kyoto University

Fukushima Medical University has
maintained a close relationship with
Kyoto University since the 2011
earthquake off the Pacific coast of
Tohoku and the subsequent
Fukushima nuclear power plant
disaster. We have also become asignificant WHS participant.

We have endeavored to rebuild
healthcare systems that are resilient.
Our struggle with this unprecedented
nuclear disaster has just started. We
must carry into the future this historic
mission entrusted to our school. It
must be carried out for the people of
Fukushima, the people of Japan, andall of mankind. We believe that thisexperience will help healthprofessionals worldwide to tackle thehealth risks associated with disasters
and environmental hazards.
The results arising from thisunprecedented meeting will certainly
strengthen preparedness for andresponses to disasters in the future.

Shin-ichi Kikuchi
President
Fukushima Medical University

009

010

WELCOME MESSAGE

WELCOME MESSAGE

Dear Friends, Dear Colleagues,
Congratulations on holding the World
Health Summit Regional Meeting Asia
in Japan for the first time.
Since 2008, Kyoto University
Graduate School of Medicine has
represented Japanese universities byparticipating in the World HealthSummit (WHS) as a member of the
M8 Alliance (the governing body ofthe WHS). We are delighted that the
M8 Alliance of Academic HealthCenters, Universities, and National
Academies has chosen Japan to hostthe third regional meeting outside
Berlin, and it is a privilege to warmly
welcome you to Kyoto to discuss
health issues.
In this meeting in Kyoto, the main
theme is “Building Resilience as
Social Responsibility of Medical
Academia”, with three major topics:
Challenges in Rapidly Aging
Societies, Preparedness for andResponse to Disasters, and Fostering
New Leadership. As a Dean,
I recognize that all of these areimportant issues to be addressed bycurrent medical academia. I havealways been proud that Kyoto
University Graduate School of

Dear Friends, Dear Colleagues,
Medicine has been an academic
leader in medical science, and that
we also recognize the social
responsibility of the School of
Medicine in this super-ageing society.
In this context, I note that in the year
2000 Japan’s first School of Public
Health was established as part of our
Graduate School of Medicine.
Leadership in medical academia
should be equally shared by basic
medical sciences, clinical medicine,and public health. With top leaders of
the world gathering here in Kyoto,
we can expect a fruitful exchange of
opinions and information about
health and medical care for the
future.

Shinji Uemoto
Dean, Graduate School of Medicine
Kyoto University

It is our great privilege to warmly
welcome you to the World HealthSummit Regional Meeting Asia, Kyoto
2015. We are delighted that the M8
Alliance of Academic Health Centers,
Universities, and National Academies
has chosen Kyoto as the meeting sitein Asia.

We are sure this WHS Regional
Meeting will greatly reinforce existing
partnerships and will allow us toaccumulate ideas for the benefit ofhealth worldwide.

Opinion leaders from academia,
politics, private sector, and civilsociety will work together on possible
solutions to health challenges
worldwide.
Our theme is “Building Resilience as
Social Responsibility of Medical
Academia”. In addition to thepressing global issues on the agenda
at the World Health Summit in Berlin(e.g. Climate Change and Health, The
Digital Health Revolution, or Global
Health Security), we have selected
three topics to discuss here:
Challenges in Rapidly Aging
Societies, Preparedness for andResponse to Disasters, and Fostering
New Leadership. These are the mostpressing challenges facing Asia for an
exchange of thoughts on the role ofmedical academia in public healthpromotion and policy making.

Shunichi Fukuhara
President of the World HealthSummit 2015
Dean, School of Public Health
Kyoto University, Japan

Detlev Ganten
Founding President of
the World Health Summit
Charité Foundation, Berlin

011

012

PARTICIPANTS AND KEY FACTS

TRACK INFORMATIONTRACK INFORMATIONKEY FACTS

The program will be organized along three tracks:

Date: April 13-14, 2015
Venue: Kyoto International Conference Center
Takaragaike, Sakyo-ku, Kyoto 606-0001 JapanTOPIC

PARTICIPANTS AND KEY FACTS

1

World Health Summit
The World Health Summit (WHS) is the annual
conference of the “M8 Alliance of Academic
Health Centers, Universities and National
Academies”. It is one of the world’s foremost
gatherings of leaders from academia, politics,
industry and civil society to develop joint
strategies and take action to address key
challenges in medical research, global healthand health care delivery with the aim ofshaping the political, academic and social
agendas.
World Health Summit
Regional Meeting Asia, Kyoto 2015
The WHS Regional Meeting Asia, Kyoto 2015,
organized by Kyoto University and co-hosted
by Fukushima Medical University, will bring
together decision makers and representativesof all health-related fields from all over theworld to address the most pressing issues that
medicine and healthcare systems will face overthe next decade and beyond.

Building Resilience

TOPIC

as
Social Responsibilityof Medical Academia

2

TOPIC
Participants Profile• Top-level researchers and members of thescientific community• High-profile political decision-makers• Executives and representatives from thehealthcare system• Leaders of the health-related industry andtechnology sector• Representatives of civil society andfoundations• Students and young professionals from all
health-related fields

Challenges in a Rapidly Aging Society
超高齢社会への挑戦

3

Preparedness for & Resilience after Disaster
自然災害への対応と準備

Fostering New Leadership
次世代リーダーシップの育成

The purpose of this meeting is to encourage trans-disciplinary discussion with special emphasis on the social
responsibility of medical academia. In addition to the pressing global health issues on the agenda at WHS in
Berlin, we have selected the above topics on the most pressing challenges facing Asia for an exchange ofthoughts on the role of medical academia in public health promotion programs and policy making.

013

014

TRACK INFORMATION

015

Key Topic - 1:
Challenges in a Rapidly Aging Society

Key Topic - 2:
Preparedness for & Resilience after Disasters

As a consequence of the growing proportion ofelderly in the population, many countries facetransitions to an aging society. With thisdemographic change, healthcare systems clearlyrequire reforms that move away from thepresent-day hospital-centered paradigm of
medicine focused on advanced medical treatment
and care to community-centered preventative
medicine. We will discuss, in the framework of thetrans-disciplinary WHS network, the role of the
medical academic community in these healthcare
reforms as well as in the prediction of people’s
needs in rapidly aging societies.

Disasters and environmental hazards are likely tohave major impacts on the lifetime health ofaffected citizens. Accurate predictions andstrategic preparations for health impairments
caused by these events are among the mostimportant responsibilities of academic medicine.
For this second topic, we will discuss our roles in a
specific event, the 2011 earthquake off the Pacificcoast of Tohoku. The academic community’sefforts to develop unified approaches throughtripartite collaborations with ministries andindustries will be presented as “the Japan model.”Key Topic – 3:
Fostering New Leadership
One of the most important missions for academic
medicine is to groom the next generation ofleaders for their role in the continuous promotionof global health. We plan to make comparisonsamong M8 Alliance members of training programsand to reexamine the aims and future directions ofour medical education systems.

Sanjusangen-do Temple

016

VISION, MISSION, GOALSVISION, MISSION, GOALSVISIONMISSION

GOALS

The vision of the World Health Summit isimproved health worldwide, catalyzed throughcollaboration and open dialogue, setting
tomorrow’s agenda for improved research,education, healthcare and policy outcomes.

The World Health Summit’s mission is to bring
together researchers, physicians, leading
government officials and representatives fromindustry as well as from non-governmentalorganizations (NGOs) and healthcare systems
worldwide to address the most pressing issues
facing medicine and healthcare systems overthe next decade and beyond.

• To engender the improvement of healthcare
worldwide by strengthening the links in place
between research, academic medicine anddecision makers across all healthcare sectors,
including government and industry.

Health is a Human Right (UN Declaration 1948).
Health and personal wellbeing are oursocieties’ most important values. However,compared to the immense rate of progress inthe medical sciences, we are lagging far behindin the global delivery of public health andhealthcare. At present, more than half of theworld’s population is not receiving proper
medical care. At the same time, demographic
change in all parts of the world results in a
rapidly rising burden of chronic diseases.
Health is more than medicine. We must clearly
define our responsibilities and investments forthe development of education, living
conditions and medicine and to increaseknowledge transfer from bench to bedside andpopulations. We can make a difference. It is
our responsibility to ensure that today’s
science becomes tomorrow’s agenda. Not only
fine-tuned coordination of initiatives ofacademia with governments, civil society andthe private sector, but also stableprivate-public partnerships and investments inhealth will accomplish our key objectives toimprove health in our world.

Health and wellbeing are not only of the highest
importance to both the individual and societies,
they are also a fundamental human right.
Governments and international institutions
should integrate health and healthcare into theirsocietal and political agendas and policies toensure that health is regarded as a public goodthat must be achieved equitably and to thehighest attainable level. To reach this goal, allstakeholders need to cooperate closely toeffectively address Global Health challenges.
The World Health Summit is the foremost annual
gathering of leaders from academia, politics,
industry, and civil society, and acts as a forum
for the development of joint strategies toaddress key challenges in medical research,Global Health and healthcare delivery, with theaim of shaping political, academic and social
agendas. Convened under the auspices of the
M8 Alliance of Academic Health Centers andUniversities in collaboration with the National
Academies of Sciences of more than 67 countries
and the InterAcademy Medical Panel, the World
Health Summit also aims to promotesustainability and social responsibility.

• To influence, guide and support positive action
by policy and decision makers through theprovision of credible and science-based
evidence.
• To maintain an international, multi-sectoral
health forum, sustaining dialogue, creating
networks, and fostering collaboration as acatalyst for innovation and measurable
healthcare improvement.
• To promote thought leadership throughacademic input into the scientific and Global
Health agenda.

017

018

WHS PRESIDENTS AND COUNCIL

WHS PRESIDENTS AND COUNCILSCIENTIFIC ADVISORY BOARD

ORGANIZING COMMITTEEADMINISTRATIVE COMMITTEE

Detlev Ganten
Founding President of
the World Health Summit
Charité Foundation, Berlin, Germany

Toshiaki Furukawa
Professor, School of Public Health
Kyoto University

CO-CHAIR
Nagahiro Minato
Executive Director, Vice-President
Kyoto University

Hiroo Imura
Professor Emeritus, the 22nd President
Kyoto University, Japan

Yuichi Imanaka
Professor, School of Public Health
Kyoto University

Kazuhiro Odani
Director, Administration Office
Faculty of Medicine Campus andUniversity Hospital
Kyoto University

Shin-ichi Kikuchi
President
Fukushima Medical University, Japan

Masahiro Kihara
Professor, School of Public Health
Kyoto University

Shinji Asonuma
Executive Director
Kyoto University, Japan

Akio Koizumi
Professor, School of Public Health
Kyoto University

Shinji Uemoto
Dean, Graduate School of Medicine
Kyoto University, Japan

Shinji Kosugi
Professor, School of Public Health
Kyoto University

Shuzo Nishimura
Director-General
Institute for Health Economics and Policy,
Japan

Toshitaka Nakahara
Professor, School of Public Health
Kyoto University

EXECUTIVE ADVISORY BOARD

Rifat Atun
Professor, Harvard University, United States
Visiting Professor, Kyoto University
Thomas S. Inui
Professor, Indiana University, United States
Professor by President's Appointment
Fukushima Medical University
Michael J. Klag
Dean
Johns Hopkins Bloomberg School of
Public Health, United States

Name by alphabetical order

CO-CHAIR
Shunichi Fukuhara
Dean, School of Public Health
Kyoto University

Takeo Nakayama
Professor, School of Public Health
Kyoto University
Koji Kawakami
Professor, School of Public Health
Kyoto University
Hidenao Fukuyama
Professor Emeritus
Kyoto University

Eiji Nawata
Professor, Graduate School of Agriculture
Kyoto University

Motoko Yanagita
Professor
Graduate School of Medicine
Kyoto University

Toshiya Sato
Professor, School of Public Health
Kyoto University

Tomohiro Kuroda
Professor
Kyoto University Hospital

Yoshihisa Shimizu
Professor, Graduate School of Engineering
Kyoto University

Rei Goto
Associate Professor
Kyoto University

Ryosuke Takahashi
Professor, Graduate School of Medicine
Kyoto University

Satoshi Okuyama
Manager, Administration Office
Faculty of Medicine Campus andUniversity Hospital
Kyoto University
Yuri Ito
Administration Office
Faculty of Medicine Campus andUniversity Hospital
Kyoto University

019

020

M8 ALLIANCE: MISSION AND GOALS

021

MISSION

GOALS

The M8 Alliance’s vision is to harness academic
excellence to improve Global Health.

The M8 Alliance is improving Global Healththrough pursuit of five strategic goals:

The M8 Alliance of Academic Health Centres,
Universities and National Academies is acollaboration of academic institutions ofeducational and research excellence
committed to improving Global Health,working with political and economic decision
makers to develop science-based solutions tohealth challenges worldwide.

• Developing a network of academic healthscience centers worldwide, bringing together
universities and healthcare providers;This international network provides an
outstanding academic foundation to the World
Health Summit – the pre-eminent annual forum
for healthcare dialogue – and acts as apermanent platform for framing future
considerations of global medical developments
and health challenges in an equitable way.
The M8 Alliance promotes the translation ofresearch progress from the laboratory'benchtop to the bedside', transformation of
our present medical care approach of treatingsick people into a true healthcare system witheffective prevention of diseases, and theadaptation of health-related solutions to ourrapidly changing living conditions throughresearch in priority areas such as demographic
shift, urbanization and climate.

• Facilitating dialogue through the World HealthSummit across a global network of
stakeholders engaged with academic healthscience centers – encompassing government,
industry and commerce, inter-governmental
agencies, healthcare providers, academies of
medicine and science, professional associations
and the media;• Setting an agenda for Global Healthimprovement through addressing issues ofinterest to academic health science centers,
and by generating key statements conveying
findings and recommendations based upon
scientific evidence;• Positioning the M8 Alliance as an authoritative,
credible and respected influence upon Global
Health decision making; and• Creating a knowledge base amongst M8
Alliance members, promoting mutual learning,
research collaboration, enrichment ofeducational capabilities and enhanced clinicaloutcomes.

Tofuku-ji Temple

022

M8 ALLIANCE: MEMBER INSTITUTION

M8 ALLIANCE: LEADERSHIPLEADERSHIP M8 ALLIANCE
Axel Radlach Pries, Charité — Universitätsmedizin Berlin, Germany
Karl-Max Einhäupl, Charité — Universitätsmedizin Berlin, Germany
Nelson K. Sewankambo, Makerere University, Uganda
Michael J. Klag, Johns Hopkins Bloomberg School of Public Health, USA
José Otávio Costa Auler Jr., University of São Paulo, Brazil
Eduardo Krieger, Brazilian Academy of Sciences, Brazil
John Eu-Li Wong, National University Health System, Singapore
Elio Riboli, Imperial College London, United Kingdom
Peter Piot, London School of Hygiene & Tropical Medicine, United Kingdom
Frédéric Dardel, Sorbonne Paris Cité, France
Gérard Friedlander, University of Paris Descartes, France
Jean-Yves Mérindol, Président, Sorbonne Paris Cité, France
Shunichi Fukuhara, School of Public Health, Kyoto University, Japan
Christina A. Mitchell, Monash University, Melbourne, Australia
Ben Canny, Monash University, Melbourne, Australia
Hélène Boisjoly, University of Montreal, Canada
Tarik Möröy, Institut de Recherches Cliniques de Montréal, Canada
Henri Bounameaux, University of Geneva, Switzerland
Antoine Flahault, University of Geneva, Université Sorbonne Paris Cité, France
Lai-Meng Looi, InterAcademy Medical Panel (IAMP), Malaysia
Detlev Ganten, InterAcademy Medical Panel (IAMP), Germany
Xuetao Cao, Chinese Academy of Medical Sciences & Peking Union Medical College, China
Depei Liu, Chinese Academy of Engineering, China
Ivan Dedov, Russian Academy of Medical Sciences, Russian Federation
Evgeny Sidorenko, Russian Academy of Medical Sciences, Russian Federation
Steve Wartman, International Association of Academic Health Centers (AAHC), USA

023

13

MONDAYAPRIL 13

Summit Program : MONDAY, APRIL

Tofuku-ji Temple

MONDAY, APRIL 13, 2015

OPENING CEREMONYGRAND PRINCE HOTELKYOTO

SUMMIT PROGRAM

OFFICIAL OPENING CEREMONY

10:30 - 11:15

HOSTS
Kyoto University
Fukushima Medical University
CHAIR
Shunichi Fukuhara
Dean, School of Public Health
Kyoto University, JapanOPENING REMARKS
Nagahiro Minato
Executive Director, Vice-President
Kyoto University, Japan
Shin-ichi Kikuchi
President
Fukushima Medical University, Japan
Shinji Uemoto
Dean, Graduate School of Medicine
Kyoto University, Japan
Detlev Ganten
Founding President of
the World Health Summit
Charité Foundation, Berlin
OPENING SPEECH
Michael J. Klag
Dean, Johns Hopkins Bloomberg
School of Public Health
M8 Alliance Executive Committee,
United States

Michael J. Klag
Dean, Johns Hopkins Bloomberg
School of Public Health
M8 Alliance Executive Committee,
United States

BIOGRAPHY
An internationally known expert
on the epidemiology andprevention of cardiovascular andkidney disease and a Johns
Hopkins faculty member since
1987, Dr. Klag became Dean of theJohns Hopkins Bloomberg Schoolof Public Health on September 1,
2005.

Dr. Klag's research has centeredon the prevention, epidemiology
and treatment of hypertension
and kidney disease. Beginning in
1988, he directed the Johns
Hopkins Precursors Study, aprospective study of Johns
Hopkins medical students thatbegan in 1946 and continues tofollow participants. This study has
made seminal contributions to ourunderstanding of how
characteristics in young adulthood
influence health and disease laterin life.
Dr. Klag also has led pioneeringstudies in kidney disease
epidemiology, including the firststudy to assess the incidence ofend-stage renal disease and to
identify blood pressure as a risk
factor for the development ofkidney failure. His work has laid
the foundation for numerous
subsequent studies.

Nagahiro
MinatoMichaelJ. KlagShin-ichi
KikuchiShunichiFukuhara

027

MONDAYAPRIL 13026

Shinji
UemotoDetlev
GantenMONDAY, APRIL 13, 2015

KEYNOTE SPEECHGRAND PRINCE HOTELKYOTO

SUMMIT PROGRAM

THE UNFINISHED AGENDA OF
INFECTIOUS DISEASES

11:15 - 12:00

CHAIR
Nagahiro Minato
Executive Director, Vice-President
Kyoto University, Japan

SPEAKER
Barry R. Bloom
Distinguished Service Professor
Harvard University, United States

BIOGRAPHY
A leading scientist in the areas ofinfectious diseases, vaccines, andglobal health and former consultant
to the White House, Dr. Bloom iswidely recognized for his importantdiscoveries in immunity totuberculosis and leprosy. He hasreceived numerous awards for his
scientific work including the first
Bristol-Myers Award in Infectious
Diseases, Robert Koch Gold Medal,
the Novartis Award in Immunology,
and the Prix Galien Pro Bono
Humanum Award. He served as Deanof the Faculty of Harvard School of
Public Health from 1998 to 2008.

OUTLINE
While non-communicable diseases
represent the greatest burden of
disease world-wide, the burden of
mortality and healthy years of life lostfrom communicable diseases isgreatest in the poorest countries.
Emerging infectious diseases, mostrecently epitomized by the Ebola
crisis in West Africa, are a constantthreat, but the major burden indeveloping countries is caused by
HIV/AIDS, tuberculosis and malaria.
While AIDS and malaria are
decreasing significantly, drug
resistance to M. tuberculosis isincreasing in many countries. Two
fundamental questions about
tuberculosis that are essential toanswer, if new more effective drugs
and vaccines against TB are to be
developed, what are the necessary
and sufficient conditions required forhumans to kill Mtb. A major focus of
our research interest has been how
intracellular pathogens, such as Mtb,
are able to avoid the usual
antimicrobial mechanisms ofmacrophages, and how innate andacquired immune mechanisms,
particularly macrophages, can be
activated to kill this formidable
pathogen. Our work and that ofothers on the immunology ofmycobacterial infection resulted in
the discovery of cytokines, theirpatterns found in different in humanlesions, and the defining manynecessary conditions in animalmodels and humans required forprotection. Studies on lesions ofleprosy indicated that the disease is
not a single clinical entity but aspectrum which correlates with thetypes of immune responses. Similarly
there is evidence that TB also
represents a clinical spectrum that
correlates with distinct immune
responses. What is lacking presently
is understanding of those conditions
that are sufficient to kill Mtb in
humans. In the course of these humanstudies with Robert Modlin’s lab at
UCLA, we found novel immunologicaland antimicrobial mechanisms forkilling Mtb and M. leprae, including avitamin-D dependent, antimicrobial
peptide mediated mechanism thatkills M.tb in activated macrophages.
This is one of several immunologicalmechanisms now being describedthat exist in humans that are notfound in experimental animal models,
indicating the importance oftranslational research in these
diseases.

029

Barry
R. Bloom

Nagahiro
MinatoMONDAYAPRIL 13028

MONDAY, APRIL 13, 2015

KEYNOTE SPEECHICCK | ROOM - A
13:15 - 14:00

SUMMIT PROGRAMNO TIME TO LOSE:LESSONS FROM AIDS AND EBOLA

CHAIR
Toshio Miyata
Executive Director
Health and Global
Policy Institute,Japan
SPEAKERPeter Piot
Director, London School ofHygiene & Tropical Medicine,
United Kingdom

BIOGRAPHYPeter Piot is the Director of the
School and a Professor of Global
Health. He was the founding
Executive Director of UNAIDS andUnder Secretary-General of theUnited Nations from 1995 until 2008,
and was an Associate Director of the
Global Programme on AIDS of WHO.
He was a professor at the Institute ofTropical Medicine, Antwerp, theUniversity of Nairobi, the College deFrance and Imperial College London.
He was a co-discoverer of the Ebola
virus, and his research focused on
HIV/AIDS, sexually transmitted
infections, and women’s health. He isa member of the US Institute ofMedicine and the UK Academy ofMedical Sciences. He published over
550 papers and 17 books, including
his memoir “No Time to Lose”. He
was knighted as a Baron in 1995, andin 2013 was the laureate of theNoguchi Africa Prize and the Prince
Mahidol Award.

OUTLINE
Whereas worldwide, chronic
conditions and injuries are the maincauses of mortality and morbidity,
infectious disease epidemics willcontinue to cause major disruption.
AIDS and Ebola are two defining,highly fatal, epidemics of our time,
the former a protracted pandemic
with no end in sight, and the latter ingeneral a more localised and moreacute outbreak. In order to ensure
more effective responses to future
epidemics, lessons from the response
to either epidemic will be considered,in particular how they can informfuture preparedness for new and oldoutbreaks, national and global
governance, the importance of
non-health sectors, of community
mobilisation, and of research andinnovation.

031

Peter
Piot

ToshioMiyataMONDAYAPRIL 13030

MONDAY, APRIL 13, 2015

SYMPOSIUMICCK | ROOM - A

SUMMIT PROGRAMGLOBAL HEALTH R&D

14:15 - 15:45

SPEAKER
Alex G. Coutinho
Chair of the IAVI Board
Kiyoshi Kurokawa
Chair of the Board, GHIT Fund
Adjunct Professor, National Graduate
Institute for Policy Studies
Chairman, Health and Global Policy
Institute, JapanBT Slingsby
CEO, GHIT Fund, Japan
Osamu Nagayama
Chairman and CEO
Chugai Pharmaceutical Co., Ltd.,Japan
Peter Piot
Director, London School ofHygiene & Tropical Medicine,
United Kingdom
Former Executive Director of UNAIDS
GHIT Fund Board Member

MODERATOR
Koichi Kaneda
Senior Director, CSR, Corporate
Communications Department
Takeda Pharmaceutical Company
Limited, JapanSESSION OUTLINE
In 2014, the Ebola outbreakthreatened public health andeconomic viability in West African
nations in major ways. Meanwhile,in Tokyo, the first dengue
outbreak in 70 years shed light on
the fact that globalization andurbanization are hastening the
spread of devastating diseases.
Furthermore, the world
recognized that the necessary
drugs, vaccines and diagnostics totackle these neglected diseases
are lacking due to a market failure
with tremendous consequences.
Clearly no one government,
company, or university can solvethese problems while creating
new life-saving tools for neglecteddiseases alone. As a result,public-private partnerships (PPP)
between government, the private
sector, and NGOs/NPOs havebecome game-changing
platforms, enabling the creation ofboth innovative financing
mechanisms and researchplatforms to facilitate open
innovation for productdevelopment. In response, theGlobal Health Innovative
Technology (GHIT) Fund wasestablished in April of 2013 as aJapan’s first PPP fund for global
health R&D between the

Government of Japan, Japan’s
leading pharmaceuticalcompanies, and the Bill & Melinda
Gates Foundation. The GHIT Fundfacilitates product developmentfor HIV/AIDS, Malaria,
Tuberculosis, and Neglected
Tropical Diseases by leveraging
Japans’ cutting-edge technology,
legacy of innovation, and successtackling infectious diseases
associated with poverty. Thispanel discussion highlights ways inwhich Japan can tackle global
health R&D even more proactively
and contribute more of its
innovation to improving global
health with greater speed andimpact. The broader issues
addressed by the WHS regional
meeting in Kyoto, such as
demographic shifts, health systemstrain, and environmental disasters
only underscore the need foraccelerated global health R&D.
Without new tools to address
infectious diseases that alreadyinfect one sixth of the world’s
population and put almost half at
risk of infection, rapid
demographic shifts and natural
disasters will continue to take anuntenable toll on the region.

Alex G.
Coutinho

Peter
Piot

Kiyoshi
Kurokawa

Koichi
Kaneda033

MONDAYAPRIL 13032

BT
Slingsby

Osamu
Nagayama

MONDAY, APRIL 13, 2015

PANEL DISCUSSIONICCK | ROOM - B1
14:15 - 15:45

SUMMIT PROGRAM

PRIMARY CARE
- THE ROLE IN SUPER AGING SOCIETY

CO-CHAIR
Izumi Maruyama
President
Japan Primary Care Association,
Japan
Thomas S. Inui
Professor, Indiana University,
United States
Professor by President's Appointment
Fukushima Medical University

SPEAKER
Amanda Howe
Professor, University of East Anglia
President-Elect WONCA (World
Organisation of Family Doctors)
United Kingdom
Leiyu Shi
Director, Johns Hopkins Primary Care
Policy Center, United States
Lee Kheng Hock
Associate Professor
Singapore General Hospital,
Singapore
Tesshu Kusaba
Vice President
Japan Primary Care Association,Japan

SESSION OUTLINE
Japan is now facing a difficulty, namely“the super aging society,” where thesmall population of young, independent
individuals must support the large
population of the elderly. In suchsocieties, it is important to provide
comprehensive care which supports the
medical and long term care of theelderly with multimorbidity. The
government is now proposing the“Community based comprehensive caresystem” and the policy is shifting in that
direction. In this system the existence ofprimary care specialists areindispensable. So far the health caresystem in Japan traditionally placedemphasis on the training oforgan-specific specialists and the sensesof capturing primary care as a
specialized area was sparse. In 2013, theJapanese government decided toestablish a new system ofcomprehensive medical specialists.
These new specialists are expected toplay an important role in Primary Care.
In this session, we would like to discuss
the challenges of Primary Care with theexperts of the world and, comparing theexamples of other countries, we would
like consider solutions from a global
perspective.

Izumi
Maruyama

Leiyu
Shi

ThomasS. Inui

Lee
Kheng HockAmandaHowe

TesshuKusaba035

MONDAYAPRIL 13034

MONDAY, APRIL 13, 2015

KEYNOTE SPEECHICCK | ROOM - A
16:00 - 16:45

SUMMIT PROGRAM

THE VALUE OF BIG DATATO MEET THE HEALTH CARE NEEDS OF
AGING SOCIETIESCHAIR
Shunichi Fukuhara
Dean, School of Public Health
Kyoto University, Japan
SPEAKERJohn Z. Ayanian
Director, Institute for Healthcare
Policy and Innovation
University of Michigan,
United States

BIOGRAPHYJohn Z. Ayanian, MD, MPP is the inaugural
Director of the Institute for Healthcare
Policy and Innovation at the University ofMichigan, which includes over 400 faculty
members from 12 schools and colleges at
the University. He is the Alice Hamilton
Professor of Medicine at the Medical
School, Professor of Health Management
and Policy at the School of Public Health,and Professor of Public Policy at the Gerald
R. Ford School of Public Policy. He also
serves as Associate Editor of the New
England Journal of Medicine.
Dr. Ayanian has published over 260 articles
and chapters on access to care, quality ofcare, and health disparities related tocancer, cardiovascular disease, diabetes,
and kidney disease. He received his BA
degree from Duke University, MD degreefrom Harvard Medical School, and Master of
Public Policy degree from the Harvard
Kennedy School of Government. He
completed his internal medicine residency
and fellowship training at Brigham and
Women’s Hospital. In 2012 he received theJohn Eisenberg National Award for Career
Achievement in Research from the Societyof General Internal Medicine. Dr. Ayanian is
a Fellow of the American College ofPhysicians and an elected member of theInstitute of Medicine.

OUTLINE
Large health care databases havegreat value to assess the quality andcosts of health care and to evaluate
health outcomes, particularly forchronic health conditions in aging
societies. These databases are widelyused in the US, and their use is
growing in Japan to study health careutilization and outcomes of adults
with major aging-related conditions,
including cancer, heart disease,stroke, diabetes, and kidney disease.
Large databases supported by theJapanese Ministry of Health, Labourand Welfare include the Diagnosis
Procedure Combination (DPC)
database and the Comprehensive
Survey of People’s Living Conditions.
Databases sponsored by the US
Department of Health and Human
Services include nationally
representative surveys such as the
National Health Interview Survey(NHIS) and National Health andNutrition Examination Survey(NHANES), hospital administrative
data such as the Nationwide Inpatient
Sample (NIS) from the Healthcare
Cost and Utilization Project (HCUP),
and clinical registries such as National
Cancer Institute (NCI) Survival,
Epidemiology and End Results(SEER) database and National Heart,
Lung and Blood Institute (NHLBI)
cohort databases.

Key findings and challenges fromstudies of large databases will bepresented, including examples from
US and Japanese studies. National
investments in large databases forhealth services research and rigoroustraining of clinical and population
health investigators to analyze these
databases have the potential tosubstantially improve health care andhealth outcomes.

037

John Z.
AyanianShunichiFukuhara

MONDAYAPRIL 13036

MONDAY, APRIL 13, 2015

SYMPOSIUMICCK | ROOM - A
17:00 - 18:30

SUMMIT PROGRAMDESIGNING A HEALTHY CITY

Trans-disciplinary collaboration to
overcome the challenge of super-aging society

CO-CHAIR
Hiroo Kinoshita
President, Kyoto International
Conference Center, Japan
Rei Goto
Associate Professor
Kyoto University, Japan

SPEAKER
Masashi Mori
Mayor, Toyama City, Japan
Shuzo Nishimura
Director, Institute for Health
Economics and Policy, Japan
Hidenao Fukuyama
Professor Emeritus, Kyoto University,
Japan
Soonman Kwon
Professor, Seoul National University,
Republic of Korea

SESSION OUTLINE
In Japan, there are wide variations
in demographics in the local
municipalities, ranging fromdensely-populated urban centers
to depopulated areas. The
first-tier local government has therole of insuring health care andmaintaining long-term care. As aresult, it is responsible forproviding integrated care.
Additionally, local governments
can implement industrial andurban policies, as well as social
security policies, to matchregional demographic variations
and different community needs.
Collaboration between
professionals with diverse
specialties is another key indesigning healthy cities with
rapidly aging populations.
We need to compare measuresand their consequences that eachmunicipality has recorded and to
determine optimal conditions that
promote the health and welfare ofcommunities.

In this symposium, we first share
the present situations dealing withthe hyper aging society of Japanand the possible changes in living
conditions and economic status of
local communities. As a successful
example, policy designs ofToyama City for a healthier cityand the program fostering humanresources for inter-disciplinary
collaborations in Kyoto University
are introduced. Then, we discuss
what policies we need to designfor developing healthy cities andthe possible implications for othercountries.

Hiroo
Kinoshita

HidenaoFukuyama

Rei
Goto

SoonmanKwon

039

MONDAYAPRIL 13038

MasashiMori

Shuzo
Nishimura

MONDAY, APRIL 13, 2015

PANEL DISCUSSIONICCK | ROOM - B1

SUMMIT PROGRAM

BIG DATA IN HEALTHCARE

17:00 - 18:30

CO-CHAIR
Takeo Nakayama
Professor, School of Public Health
Kyoto University, Japan

SPEAKER
Yuichi Imanaka
Professor, School of Public Health
Kyoto University, Japan

Adam Tanner
Fellow, Harvard University,
United States

Shinya Kimura
ChairmanJapan Medical Data Center Co., Ltd.,JapanJohn McNeil
Professor, Monash University,
Australia

041

SESSION OUTLINEInterest in Big Data is rapidly increasing
worldwide and it is getting more andmore popular in the field of healthcare.
Its features are often described as “4V”;
Volume, Velocity, Variety, and Veracity.
Besides these, the society is also
expecting to gain new “Vision” and“Value” which could eventually be foundthrough the use of big data. Big data is“common lands of information” where
people who make up a society bring
together information and benefit from it.
Big data in general consists of not only
medical related information but also awide variety of information.
In this session, we will explore thecurrent situation of big data in the worldin general and discuss challenges andfuture perspectives of utilizing big datain healthcare.

Takeo
Nakayama

ShinyaKimuraAdam
TannerJohn
McNeilYuichiImanaka

Kuo-Liong
Chien

MONDAYAPRIL 13040

Kuo-Liong Chien
Professor, National Taiwan University,
Taiwan14

TUESDAY
APRIL 14

Summit Program : TUESDAY, APRIL

Tofuku-ji Temple

TUESDAY, APRIL 14, 2015

SYMPOSIUMICCK | ROOM - A
10:00 - 11:30

SUMMIT PROGRAM

PHYSICAL ACTIVITY AND SPORTSport Events and Sport for All

CO-CHAIR
Hisashi Sanada
Professor, University of Tsukuba
Chairman of TIAS, Japan
Atsuyuki Asano
Director
Olympic and Paralympic Games
Ministry of Education, Culture, Sports,
Science and Technology, Japan

SPEAKER
Ugur Erdener
Executive Board Member of IOC
Chairman of IOC Medical Commission
Professor, Hacettepe University,
TurkeyJens V. Holm
Chief Executive Officer
International Masters Games
Association
Koji Murofushi
Professor
Tokyo Medical and Dental University
Olympic Gold Medalist
Board member of TOCOG*, Japan*TOCOG: The Tokyo Organising Committee of the Olympic and Paralympic GamesSESSION OUTLINEThe Olympic Movement by the
IOC includes the following six
topics: Sport for All; Education;
Women and Sport; Sport andEnvironment; Development
through Sport; and, Peace throughSport. This means ‘Sport for All’ isa very important pillar of the
Olympic Movement.
Also in Japan, Jigoro Kano who
founded the Nippon Sport
Association in 1911 promoted theidea that not only the athletic
ranking in the world but also thedevelopment of Sport for All isimportant. Moreover, the following
two visions of the 2020 Tokyo
Olympic and Paralympic Gamesalso highlight the importance ofSport for All.
- We arrange the environment
for the people to do sport
eternally whenever and wherever
they want.
We should show the importantrole of sport in the improvementof physical fitness and promotionof health for the people in an
aging society.

Since Japan has entered into an
era of a low birthrate and aging
society, the idea of a healthy life
expectancy becomes additionally
important. When all the people,
young and elderly alike, would be
able to participate in sports, ahealthy life expectancy will be
prolonged. Sports also lead to apeaceful, safe and barrier-freesociety for elderly people.

Hisashi
SanadaUgur
Erdener

AtsuyukiAsano

Jens V.
Holm

045

From these points, we would liketo access the sport events in lightof Sport for All.

Koji
Murofushi

TUESDAY
APRIL 14044

TUESDAY, APRIL 14, 2015

PANEL DISCUSSIONICCK | ROOM - B1

SUMMIT PROGRAMHEALTH TECHNOLOGY ASSESSMENT (HTA)

10:00 - 11:30

CO-CHAIR
Koji Kawakami
Professor, School of Public Health
Kyoto University, Japan
Mondher Toumi
Professor, Aix-Marseille University,
FranceSPEAKER
Akira Morita
Director-General, National Institute ofPopulation and Social Security
Research, Japan
Mondher Toumi
Professor, Aix-Marseille University,
FranceJohn Zalcberg
Professor, Monash University,
Australia

SESSION OUTLINE
The budget control objective ofdeveloped countries is challenged
by the increased needs ofhealthcare for an aging populationand the reimbursement ofexpensive new innovative
therapies. An increasing numberof countries did adopt HealthTechnology Assessment (HTA) as
a tool to drive reimbursement of
medicine, medical devices ormedical procedures. Although thegeneral vision is similar acrosscountries, different decisionframeworks have been adopted
and the impact of HTA vary
dramatically across countries. HTA
are regularly subject tocontroversies, one suggesting that
HTA prevents access to importanttherapies for patients while others
support that HTA is a criticalcontributor to sustainability of thehealthcare system. Within such acontext, this session aims toaddress the following topics:* How existing HTA have been
impacting access to newtechnologies and the budget ofpayers?
* How different models variously
impact the level of access and thebudget of payers?
* Is there an opportunity to learn
from existing HTA and avoid
duplication of work within all
HTA?
* Is the development of the
Affordable Care Organization in
the US a threat or a new life for
HTA?
* HTA 2020 around the world.

Koji
Kawakami

047

Mondher
Toumi

Akira
MoritaJohn
Zalcberg

TUESDAY
APRIL 14046

TUESDAY, APRIL 14, 2015

PANEL DISCUSSIONICCK | ROOM - B2
10:00 - 11:30

SUMMIT PROGRAM

FOSTERING NEW LEADERSHIPIN MEDICAL ACADEMIA

CO-CHAIR
Thomas S. Inui
Professor, Indiana University,
United States
Professor by President's Appointment
Fukushima Medical University
Shunichi Fukuhara
Dean, School of Public Health
Kyoto University, Japan

SPEAKERBen Canny
Associate Dean, Medical School
Monash University, Australia
Josef Coresh
Professor, Johns Hopkins Bloomberg
School of Public Health, United States
Antoine Flahault
Professor, University of Geneva,
Switzerland
Thomas S. Inui
Professor, Indiana University,
United States
Professor by President's Appointment
Fukushima Medical University

SESSION OUTLINE
Academic Health Science Centers(AHSCs) are privileged institutions
within the societies they serve. While
there are variations from one nationalsetting to another, AHSCs usually
have access to special financial
resources (for example, grants,
funding for specialty services,
programmatic and center of
excellence support), some of the best
and brightest university-level
students, and freedom from taxation.
In return for this special status, muchis expected in return by the bodypolitic (ministry of health, national
legislature and other policy makers).
The shifting scene of today’senvironment complicates what AHSCs
must do to continue to merit their
special status.
As rapid changes occur in an AHSC’s
host society, the values and needs
people bring to medicine and medicalcare are changing. The ‘aging’ of ourpopulations, easy access tolay-language technical information on
the Internet, widespread use of
telecommunications are all increasing
the sophistication, aspirations anddemands of the patients AHSCs serve.
In some of the developed world,
AHSC quality of care, educational
ranking among peer schools andscientific productivity are all public
information. Reputations are at stakeand market competition among
AHSCs may arise.
In order to meet the needs anddemands of their host societies in thiscomplex and dynamic environment,

AHSCs must be better attuned totheir accountabilities and better
managed than ever before in history.
Their several ‘product lines’(education, scientific, health caredelivery enterprises and compliancewith national/regional and local
policies) must flow from careful,mission-focused orchestration of
AHSC effort, financial resources, andinfrastructure (like information
systems, equipment, and space) withgreat efficiency and minimal waste.
Because AHSCs in many settings area collection of institutions (forexample, university, healthprofessions schools and hospitals)
with relative independence,
integration of core AHSC enterprises
across these institutions requiresalignment and coordination andteamwork by the executive
leadership of diverse institutions,
often leadership with different
perspectives and incentives.
One of the core mission
responsibilities of AHSCs is tocultivate and prepare young leaders
for their roles and responsibilities in
the AHSCs of the future. The
development of such personnel iscertainly one of the greatest social
responsibilities medical academia has.
Taking advantage of the opportunity
to bring together the representativesof the leading universities of theworld, we would like to discuss thevision and strategy for AHSC humanresource development and how
medical academia can respond to thischallenge.

ThomasS. Inui

Josef
CoreshShunichiFukuhara

AntoineFlahault

049

Ben
Canny

TUESDAY
APRIL 14048

TUESDAY, APRIL 14, 2015

SPECIAL LECTURE(with Lunch)
ICCK | ROOM - A
12:00 - 12:45

SUMMIT PROGRAMRESPONSIBLE AND
INNOVATIVE CYBERNIC SYSTEMSFOR AGING SOCIETY

CHAIR
Lise GauvinProfessor
Université de Montréal, Canada

SPEAKER
Yoshiyuki Sankai
Professor, Center for Cybernics
Research, University of TsukubaCEO, CYBERDYNE Inc., Japan

BIOGRAPHY
Yoshiyuki Sankai acquired a Ph.D. in
Engineering from the University ofTsukuba, Japan, in 1987. He has
progressed from being a Japan
Society for the Promotion of Science
Research Fellow to AssistantProfessor, Associate Professor, andProfessor at the Graduate School of
Systems and Information
Engineering, University of Tsukuba.
Dr. Sankai is also a Visiting Professor
at Baylor College of Medicine,
Houston, Texas, United States.
Currently, he is Professor andDirector at the Center for Cybernics
Research, University of Tsukuba, thePresident and CEO of CYBERDYNE
Inc., and a Program Manager of the
Impulsing Paradigm Change throughDisruptive Technologies (ImPACT)
Program, initiated by the Council for
Science, Technology and Innovationof the Cabinet Office, Japan.
He is a fellow of the international
journal of the Robotics Society ofJapan (RSJ) (2012). He also served as
Chairman (2005) and Executive
Board member (2004-2005) of
Advanced Robotics, as well as
Executive Board member(2000-2012), congress head (2003),
and fellow (2005) of the Japan
Society of Embolus Detection &Treatment. He has been a council
member on one of the Global Agenda
Councils of the World Economic
Forum.
He has pioneered innovative
Cyborg-type robot technology in a
new academic field called“Cybernics” and established a social
problem-solving venture company.
He led the intellectual property
strategy and international standard
setting by ISO as an expert memberof the committee on medical robots.
His Robot Suit HAL acquired the CE
marking certification for medical
devices and its use for medical
treatment is being covered by the
public worker’s compensation
insurance in Germany.

051

Yoshiyuki
Sankai

Lise
GauvinTUESDAY
APRIL 14050

TUESDAY, APRIL 14, 2015

KEYNOTE SPEECHICCK | ROOM - A
13:15 - 14:00

SUMMIT PROGRAMHEALTHY AGING:
WHAT CAN JAPANESE SOCIETY TELL US ?

CHAIR
Hideki Hashimoto
Professor
Graduate School of Medicine
The University of Tokyo, Japan
SPEAKER
Ichiro Kawachi
Professor
Harvard School of Public Health,
United States

BIOGRAPHY
A world renowned researcher who
was seminal in establishing the fieldof “Social Epidemiology”, Dr. Kawachi
has conducted investigations on thedamaging population healthconsequences of inequality, as well associal capital as a determinant ofcommunity wellbeing. He was theco-editor (with Lisa Berkman) of thefirst textbook on Social
Epidemiology, published by Oxford
University Press in 2000; now in its
second revised edition. He is theauthor of eleven other books. He is
the Co Editor-in-Chief (with SV
Subramanian) of the international
journal Social Science & Medicine andan elected member of the Institute ofMedicine of the US National Academyof Sciences.

This session is sponsored by The Naito Foundation.

OUTLINE
Healthy aging is defined as the ability
to maintain optimal physical, mental,
and social well-being as we age. The
opportunity for healthy aging is notjust limited to those individuals who
manage to remain free of disease anddisability as they grow older; such a
restrictive definition would apply only
to a minority of the population (lessthan five percent). The concept ofhealthy aging is much broader than
the absence of disease or disability; itacknowledges the potential for evenolder individuals with chronic
conditions to experience productive
and fulfilling lives.
Healthy aging is dependent on notjust the quality of medical care, but
on people’s experiences of social
conditions throughout theirlife-course. The World HealthOrganization defines the social
determinants of health as “theconditions in which people are born,
grow, learn, work and age.” Healthy
aging is dependent on the quality ofschooling we receive in youth, accessto safe and secure jobs, theavailability of decent housing, public
transport, and residential environmentsthat provide opportunities for social
interaction.

Japanese society is experiencing thefastest rate of population aging in theworld. In this presentation I will focus
on the social determinants of healthy
aging in Japanese society. In
particular, what can the rest of theworld learn from the Japanese casewith regard to the opportunities topromote healthy aging? What are thebarriers and threats to healthy aging
in society?

053

IchiroKawachi

Hideki
HashimotoTUESDAY
APRIL 14052

TUESDAY, APRIL 14, 2015

SYMPOSIUMICCK | ROOM - A
14:15 - 15:45

SUMMIT PROGRAM

SOCIAL CONNECTEDNESS AND
HEALTHY AGING

CO-CHAIR
Ichiro Kawachi
Professor
Harvard School of Public Health,
United States
Katsunori Kondo
Professor
Chiba University, Japan

SPEAKER
Jun Aida
Associate Professor
Tohoku University, Japan
Kokoro Shirai
Associate Professor
University of the Ryukyus, Japan
Hiroyuki Hikichi
Visiting Scientist
Harvard School of Public Health,
United States
Katsunori Kondo
Professor
Chiba University, JapanSESSION OUTLINE
Healthy aging is defined as theability to maintain optimal
physical, mental, and social
well-being as we age. Promoting
the healthy aging of the
population depends critically on
the adoption of healthy behaviors,such as eating a healthy diet andregular physical activity. However,in addition to healthy lifestyles,
there is growing recognition of theimportance of social
connectedness as a way topromote healthy aging. Social
scientists and gerontologists alikehave long recognized that thequality of our social relations is
crucial to our ability to age
successfully. Active social
participation and civic
engagement are critical tomaintaining optimal physical andcognitive functioning.
“Social capital” is a concept used
to describe the quality of oursocial connections. Social capitalis defined as the resources thatpeople can access through theirsocial relationships; it recognizes
that social connections in our daily
lives have value, and that theadvancement of wellbeing insociety should look beyond theaccumulation of wealth (financial

capital) or knowledge and skills(human capital).
In this session we will explore theimportant lessons learned fromepidemiological studies of the
impact of social connectedness on
health. The panel speakers will
highlight the empiricalcontributions of the ongoing
Japan Gerontological Evaluation
Study (JAGES). The topics will
include: (a) how can social
participation promote healthy
aging?; (b) how does community
social capital contribute todisaster resilience and recovery?;and (c) how can policies promotesocial capital and social
connectedness?

IchiroKawachi

KokoroShirai

Katsunori
Kondo

Hiroyuki
Hikichi

055

Jun
Aida

TUESDAY
APRIL 14054

TUESDAY, APRIL 14, 2015

PANEL DISCUSSIONICCK | ROOM - B1
14:15 - 15:45

SUMMIT PROGRAM

BUILDING A RESILIENT HEALTHCARE SYSTEM- LESSONS LEARNED FROM FUKUSHIMA

CO-CHAIR
Hitoshi Ohto
Vice-President
Fukushima Medical University,
Japan

SPEAKER
Mitsuru Munakata
Professor
Department of Pulmonary Medicine
Fukushima Medical University, Japan

Koichi Omori
Professor
Department of Otolaryngology
Fukushima Medical University,
Japan

Seiji Yasumura
Professor
Department of Public Health
Fukushima Medical University, Japan
Shigeatsu Hashimoto
Professor, Department of the Health
Examination and Promotion
Fukushima Medical University, Japan
Rifat Atun
Professor
Harvard School of Public Health,
United States
Visiting Professor, Kyoto University

057

SESSION OUTLINEThe Great East Japan Earthquake andTsunami hit the coast of Japan on March
11, 2011. Its impact on the health andmedical care system has not lasted, yet
it will continue in a long-term basis.
In this session, we will introduce theexperience of Fukushima; 1) what
happened in Fukushima just after thedisaster, 2) actions taken by the
Fukushima Medical University in anacute phase, and 3) health problems
caused by evacuation in a chronic phase.
We will also introduce the healthcare
reforms and findings obtained after the
major earthquake in western Turkey in1999.

Hitoshi
Ohto

Seiji
Yasumura

Koichi
Omori

Shigeatsu
Hashimoto

Mitsuru
Munakata

Rifat
Atun

Taking this tragic disaster as anopportunity to rebuild an ideal societythat is resilient to disaster, it is important
to identify the problems of the Japanese
medical care and social system. The
world is paying attention how Japan
would approach these challenges.

TUESDAY
APRIL 14056

TUESDAY, APRIL 14, 2015

SPECIAL LECTURE
ICCK | ROOM - A
16:00 - 16:45

SUMMIT PROGRAM

RETINAL REGENERATIVE MEDICINEUSING IPS CELLSCHAIR
Hiroo Imura
Professor Emeritus(the 22nd President)
Kyoto University, Japan
SPEAKER
Masayo Takahashi
Project Leader
RIKEN Center for Developmental
Biology, Japan

BIOGRAPHY
Dr. Masayo Takahashi, a Top 10
Scientist selected by Nature in 2014,
led the world’s first transplant of tissue
generated from iPS cells into a person.
Dr. Masayo Takahashi specializes inOphthalmology, graduated from Kyoto
University’s School of Medicine andperformed research there for several
years after obtaining an M.D. in 1992.
She joined RIKEN in 2006 as a teamleader in the Kobe Institute and fromthere on she conducted research on
retinal regeneration at the RIKEN
Center for Developmental Biology
while practicing as a physician at the
Department of Ophthalmology of Kobe
City Medical Center General Hospital.
Since 2008, she has also been a leaderof the Visual Regeneration ResearchGroup at the Institute of Biomedical
Research and Innovation Hospital. She
was the first researcher who succeededin generating retinal cells and retinal
pigment epithelial cells (RPECs), firstfrom ES cells, and then from iPS cells.
She is now leading the first humanclinical studies using iPS cells to treat
patients suffering from age-related
macular degeneration.

OUTLINE
The first man-related application of
iPS-derived cells started in
September 2014 targeting an
incurable retinal disease called
age-related macular degeneration(AMD). AMD is caused by thesenescence of retinal pigment
epithelium (RPE) that affect thecenter of the retina (macula). It is amajor cause of visual impairment inadvanced countries. We aim todevelop a treatment that replaces
damaged RPE with normal, young
RPE made from patients’ own iPS
cells to rescue photoreceptors in theneural retina.
In the clinical study, we judge theoutcome one year after the surgery.
Grafted cell sheets went throughvarious tests and tumorigenicity tests
use immunodeficient mice to checkthe safety. The primary endpoint issafety, and mainly tumor formationand immune rejection will bechecked.
One of the issues of regenerative
medicine is that expectation becomes
hype. In this clinical study, efficacy
such as increases in retinal sensitivity
is the secondary endpoint. Hype
comes from a way of thinking that acure is the only way for a solution. In
retinal regenerative medicine, visualfunction might remain low even after
successful treatment, so thatregenerative medicine will beaccomplished following rehabilitation(low vision care).
In Japan, pharmaceutical laws havebeen changed and a new chapter forregenerative medicine was
generated. This is the first law
specifically for regenerative medicine
in the world. It was determined incooperation with ministries andacademia and its success will dependon the cooperation with ministries
and academia. I will discuss about the
future of regenerative medicine inJapan.

059

Hiroo
Imura

MasayoTakahashi

TUESDAY
APRIL 14058

TUESDAY, APRIL 14, 2015

CLOSING CEREMONYICCK | ROOM - A

SUMMIT PROGRAM

Ugur Erdener
Executive Board Member of IOC
Chairman of IOC Medical Commission
Professor, Hacettepe University, Turkey

CLOSING CELEMONY

17:00 - 18:00

HOSTS
Kyoto University
Fukushima Medical University
CHAIR
Shunichi Fukuhara
Dean, School of Public Health
Kyoto University, JapanBEST POSTER AWARD
Eduardo Krieger
Executive Diretor for International
Affairs
University of São Paulo Medical
School, Brazil
SUMMARY OF REGIONAL MEETING
Thomas S. Inui
Professor, Indiana University,
United States
Professor by President's
Appointment
Fukushima Medical University

061

CLOSING SPEECH
Ugur Erdener
Executive Board Member of IOC
Chairman of IOC Medical Commission
Professor, Hacettepe University,
TurkeyHiroo Imura
Professor Emeritus(the 22nd President)
Kyoto University, JapanINTRODUCTION TO WHS2015
Ben Canny
Associate Dean, Medical School
Monash University, Australia
M8 Alliance Executive Committee
CLOSING
Detlev Ganten
Founding President of the World
Health Summit
Charité Foundation, Berlin, Germany

BIOGRAPHY
Dr. Ugur Erdener is a physician specialized in
ophthalmology and is also an athlete in the triple jump
and a renowned basketball player. He is currently amember of the International Olympic Committee andPresident of the National Olympic Committee of Turkey.
He has published over 65 articles on ophthalmology inboth foreign and domestic journals. He has received
many awards in the fields of both medicine and sport;
selected as Turkey’s Sportsman of the Year four times.

Hiroo Imura
Professor Emeritus(the 22nd President)
Kyoto University, Japan
BIOGRAPHY
Dr. Hiroo Imura is a leading medical scientist in Japan in
the field of endocrinology and diabetology. He had been
Professor of Medicine and then served as President of
Kyoto University for 6 years. He then became an
executive member of the Council of Science andTechnology Policy which is an advisory body to thePrime Minister in science and technology policy. He is
now President, Foundation for Biomedical Research andInnovation in Kobe Biomedical Cluster and President, the29th General Assembly of Japan Medical Associations.

EduardoKrieger

Hiroo
Imura

ThomasS. Inui

Ben
Canny

Ugur
Erdener

Detlev
GantenTUESDAY
APRIL 14060

ShunichiFukuhara

GENERAL INFORMATION
AND MAPS

Shinsen-en Temple

102

SUMMIT VENUE

SUMMIT VENUE

WC

2F

Kyoto International Conference Center[ICC Kyoto]

ROOM - A
Plenary HallEV

EV

Bus Terminal[Kokusaikaikanekimae]

Takaragaike St.

SUBWAY LINE

Grand Prince Subway
Hotel Kyoto Exit 4 -2

ICC Kyoto

WC

Kokusaikaikan
Kitayama
Parking

ROOM - B2

EV

Matsugasaki
Annex
Hall

N

ijo

ijo

River

Entrance

Kyoto
International
Conference Center(ICCK)

Marutamachi

joNGrand Prince
Hotel
Kyoto

TunnelImadegawaEvent Hall

-m

Event
Hall

Main
Building

Kuramaguchi

SubwayExit 4-2

Kokusaikaikan
StationP Parking Lot

to Main
Entrance

Kitaoji

ROOM - B1

3 Subway
Exit

Underground
Passage

Lake
Takaragaike

ICC Kyoto

Karasuma Oike

ae

Sh

N
U
Te zum ish
nj a ioj
in sa
i O Shijo
ga
ik
w
e
a

iy

ak

Sa

Gojo

Keage

ga
Misasagis
Ke hiyyo
ih am
Yamashina
-m an
a
ae

us

Kyoto
Station

Hi

nj

o-

Higashino

Kujo
Annex Hall

Entrance

1F

Ground
Floor

Jujo

Pond
GardenKuinabashi

Nagitsuji
Ono

TakedaDaigo
IshidaRokujizo

Subway Karasuma Line
Subway Tozai Line
14min. from Karasuma Oike
16min. from Shijo
20min. from Kyoto

Shirakawa St.

Takaragaike, Sakyo-ku,
Kyoto 606-0001, Japan
Tel: +81-75-705-1229
Fax: +81-75-705-1100

AREA MAP

103

104

PUBLIC TRANSPORTPUBLIC TRANSPORT
Kyoto International
Conference Center

Kokusaikaikan

ICC Kyoto

Lake
Takaragaike

Ideally located, with excellent accessfrom all over the world and anywhere in Japan

Imadegawa st.

Shirakawa st.

Higashioji st.

Take the Kyoto South or Kyoto East exit andfollow the signs to “Kyoto International Conference Center.” (40min.)Kyoto
Shiyakusyo-mae
Higashiyama
Keage
Sanjo
KeihanShijo Karasuma

Shijo
Kawaramachi

Shijo

Gojo

Shichijo st.
Kyoto

to Osaka

Kujo st.

Hanshin Expressway

Meitetsu Express + JR Shinkansen(approx. 80min.)

ay

ilw

Ra

Kamo River

Subway: Karasuma Line
from Kyoto Station, 20min.

Keihan Railway

JR Kyoto Station

ImadegawaKawaramachi st.

Limousin bus (approx. 55min.)Gojo st.

Kinki Nippon Railway Kyoto Route

JR Haruka Airport Express (75min.)Limousin bus (approx. 75min.)

Kuramaguchi

Karasuma st.

Nijo
StationMeishin Expressway

Sanjo Station

r

ve

Ri

Misasagi

ICC
Kyoto

er

Access by Road

Keihan Main Line

Karasuma Station

Subway: Tozai Line &Karasuma Line
from Sanjokeihan Station,
about 20min.

Eiz

Karasuma
Oike

Nijojo-mae

Hankyu Railway

Riv

Centrair International
Airport (Nagoya)

Oike st.

sura
KatOsaka International
Airport (Itami)

JR Kyoto Linean

Marutamachi

Omiya st.

Hankyu Kyoto Line

Kansai International
AirportNishioji Oike

Kitaoji

Nijo Subway Tozai Line

Shijo st.

Kyoto International Conference Centerfrom Osakaand Kobe

JR Kyoto Station

Subway: Karasuma Line
from Kyoto Station, 20min.
from Shijo Station, 16min.

Horikawa st.

Marutamachi st.

Keifuku Railway

from Kyushu
and Chugoku

Access by Air

Senbon st.

San-in Trunk Line

to Kameoka

Access by Rail

JR Sanyo Shinkansen

Subway Karasuma Line

Kitayama st.

Uzumasa Tenjingawa

JR Tokaido Shinkansen

o

n
ka

Ta

KOKUSAIKAIKAN

to Arashiyama

from Tokyo, Shinagawa
and Nagoya

Matsugasaki

Kitayama

Nishioji st.

Since Kyoto is located more or less at the centerof Japan, it enjoys a strategic position in thetransport network and excellent accessibility.
Kyoto’s central railway station can be reachedfrom Kansai International Airport in 75 minuteswith the “Haruka” airport express service, andfrom Osaka International Airport in Itami in 55
minutes by limousine bus. ICC Kyoto(“Kokusaikaikan” station) can be reached from
Kyoto station in just 20 minutes by the Karasuma
subway line. From the Tokyo metropolitan area
Kyoto can be reached in about two and a half
hours by Shinkansen (Bullet Train) with easytransfer to subway at JR Kyoto station.

Yase

to Osaka

to Shin Osaka

Kyoto
StationYamashina
Yamashina
StationTokaido Line
Kyoto East
Interchange

Tokaido Shinkansen(Bullet Line)

to Tokyo

Kujo
Kamitoba
Ramp
Jujo

Kuinabashi
Takeda

y

sswa

xpre

hin E

Meis

Kyoto SouthInterchange
to Nara105

106

ABOUT THE HOST CITY

ABOUT THE HOST CITY

CITY OF KYOTO

京都

Sapporo

Kyoto

Osaka

Okinawa

KYOTO IS A PLEASURE ALL SEASONS AND

Formerly the imperial capital of Japan for more

WEATHERS.

than 1,000 years, the city is now home to 1.5

Kyoto has a temperate northern hemispheremillion people and a major part of the Kyoto-climate with clearly defined seasons andOsaka-Kobe metropolitan area. The city limits

predictable weather patterns. April heralds a

contain opportunities to experience leading

warm spring full of excitement for celebrating

modern technology and architecture, neonmuch cherished cherry blossoms. Innumerable

lights and deafening gaming parlors, gracefulgreen hues in temple areas offer respite fromgeisha (known as Geiko and Maiko in Kyoto)summer heat. Autumn brings bright reds andand serene Buddha, a formidable castle andyellows that harmonize with the historicsecluded temples, and even lush green ricemonuments from October to December. The

paddies. There is a great deal to see andsilence brought by an occasional dusting ofexperience in this city during free time in thesnow is said to be the best way to appreciate

Kyoto is a city located in the Kansai region,

business schedule and for accompanying

Kyoto during winter.

famous for its natural scenery, temples, shrines,

persons who want to venture off site. The city

towns and homes intermingle with a poignant

also offers visitors endless opportunities to

Also, Kyoto residents are renowned for their

historical beauty.

gain meaningful hands-on experience of rich

hospitality: Outstanding service is part of the

Also known as the City of Ten Thousand

Kyoto culture through Tea Ceremony, sakecity pride. Therefore rest assured that wher-

Shrines, the cityscape is dominated by 2000

brewing, kimono wearing, swordsmanship, andever you go, be it meeting venues, hotels,

temples and shrines, and 17 traditional loca-

more. Each season brings festival and event

restaurants or enchanting cobbled lane, youtions in Kyoto were inscribed on UNESCO’s

highlights that date back to the foundation ofwill be welcomed with all the warmth of theWorld Heritage List in 1994.

Kyoto in the eighth century.

culture heart of Japan.

Tokyo
NagoyaFukuokaA MIXTURE OF ANCIENT AND MODERN

The rich heritage is reflected in modern technical advances. Kyoto is packed with opportunities to rub shoulders with new frontier industries and top Japanese scholars. Kyoto is oneof the academic centers in Japan and home toaround 40 institutions of higher education, andin fact, half of all Japanese Nobel Prize winners
have been Kyoto University researchers.

107

SIGHTS OF KYOTO

SIGHTS OF KYOTO

ICC Kyoto

C

B

Matsugasaki

Kitayama

o

n
ka

r

Ta

4

Imagawa st.

2

Nijo

Hankyu Railway

Shijo st.

Shijo

ay
Subway Tozai Line

Shijo
Karasuma

11

12

14
Kyoto

to Osakar
Rive
to OsakaN

KYOTO
StationTokaido Line

Misasagi

Yamashina

13
Kyoto East
Interchange

Tokaido Shinkansen(Bullet Line)

Kujo

to Tokyo

16

Kamitoba
Ramp

O

17
Takeda1

B Kamigamo-jinja Shrine

2 Shisen-do Temple

C Kozan-ji

3 Genko-an Temple

D Kinkaku-ji Temple (The Golden Pavilion)

4 Daitoku-ji Temple

E Ryoan-ji Temple

5 Daikaku-ji Temple

F Ninna-ji Temple

6 Kitano-tenmangu Shrine

G Shimogamo-jinja Shrine

7 Myoshin-ji Temple

H Ginkaku-ji Temple(The Silver Pavilion)

8 Kyoto Imperial PalaceI

Nijo-jo Castle

9 Heian-jingu Shrine

J Tenryu-ji Temple

10 Nanzen-ji Temple

K Saiho-ji Temple (Koke-dera Temple)

11 Shoren-in Temple

L Kiyomizu-dera Temple

12 Yasaka-jinja Shrine

M Nishi-Hongwan-ji Temple

13 Sanjusangen-do Temple

N To-ji Temple

14 Higashi-Hongan-ji Temple

O Daigo-ji Temple

15 Katsura Imperial Villa

P Byodo-in

16 Tofuku-ji Temple

Q Ujigami-jinja

17 Fushimi Inari-taisha Shrine

xpre

hin E

Meis

http://www.city.kyoto.jp/koho/eng/index.html

Kyoto SouthInterchange
to NaraP

Q

Temples, Shrines and Others

A Mt. Hiei-zan Enryaku-ji Temple

y
sswa

→

to Shin Osaka

Kujo st.

Hanshin Expressway
Kinki Nippon Railway Kyoto Route

sura

Kat

15

Kamo River

Omiya st.

M

Keage

L

Gojo st.

Shichijo st.

10

Higashiyama

Shijo
Kawaramachi

K

ailw

Karasuma
Oike
Sanjo Keihan

Keifuku Railway

9

Kyoto
Shiyakusyo-mae

Oike st.
Nijojo-mae

HShirakawa st.

8

Higashioji st.

Nishioji Oike

In Kyoto, there are 17 castles, temples andshrines which are registered as World
Heritage Sites. The years in which they
were built vastly range from before 794
CE, when the capital of Japan wastransferred to Heian-kyo (current
Kyoto-city), to the Edo period of
1603-1868 CE.

World Heritage
Keihan Railway

I

Nijo
Uzumasa
Tenjingawa

Kuramaguchi

Marutamachi st.

to Arashiyama

J

G

Kawaramachi st.

San-in Trunk Line

KitaojiKarasuma st.

7

Horikawa st.

Nishioji st.

Senbon st.

6

to Kameoka

Subway Karasuma Line

D

5

1

ve

Ri

Kitayama st.

E

A
Yase

3

F

Kokusaikaikan

Lake
Takaragaike

Eiza
nR

108

Shugakuin Imperial Villa

109

110

ABOUT KYOTO UNIVERSITYSCHOOL OF PUBLIC HEALTHABOUTKYOTO UNIVERSITY

Kyoto University was founded by

Graduate School of Medicine

School of Public Healthimperial ordinance on 18 June 1897, theSoon after the foundation of Kyoto University,

Kyoto University School of Public Health wassecond university to be established in

the Graduate School of Medicine was founded

established in 2000, and was the firstJapan. Kyoto University currently has 10

in 1899 and has greatly contributed to society

institution of its kind in Japan, offering thefaculties, 17 graduate schools, 14

with its advanced education and research ofdegrees of Master of Public Health (MPH) andresearch institutes, and 21 research andthe highest standards. It has produced

Doctor of Public Health (DrPH). The school

educational centers.

numerous world leading scholars andexplores the integrated socio-ecologicalresearchers of medicine and a continuous

approach for health, referred to as the “NewKyoto University states its mission to

stream of medical treatment and research

Public Health.”

sustain and develop its historicalfindings of great originality.

commitment to academic freedom andTo meet the new health challenges of the 21stto pursue harmonious coexistence within

The Graduate School of Medicine has overthe human and ecological community on

1,300 undergraduate students, 1,000 graduatesuch as communicable and chronic disease

this planet.

students and around 440 faculty members

control, family health, nutrition andwith 120 administration staff.

environmental health with new fields such as

Graduate School of Medicine

century, it combines classic public health fields

clinical epidemiology, pharmacoepidemiology,socioepidemiology, behavioral science, healthpromotion, informatics, economics, and ethics.
School of Public HealthThis innovative approach to public health ispursued by the school’s 18 departments, which
welcome motivated students and professionals
from around the world with diverse
backgrounds, including the medical, natural

Graduate School of Medicine in 1914
(Kyoto University Archives)and social sciences.

111

112

ABOUT FUKUSHIMA MEDICAL UNIVERSITYABOUT FUKUSHIMA MEDICAL UNIVERSITYABOUT
FUKUSHIMA MEDICAL UNIVERSITY

Fukushima Medical University (FMU) was

To fulfill the desire of Fukushima citizens toestablished in 1944 with a mission to lead“enjoy a lifetime of health and wellness”, FMU

the medical community in Fukushima

is committed to providing high quality medical

Prefecture.

services as the core medical institution in
Fukushima Prefecture, while ceaselessly

FMU includes a School of Medicine and a

striving to advance its medical skills. It is also a

School of Nursing. Both schools haveresearch institute with an aim to contribute toeducated specialists who contribute to

the community and the welfare of humanity

health and welfare throughout Japan.

through advances made in medicine, nursing
and related areas.

FMU has 630 faculty members, 1,044
undergraduates, 207 Graduates students,

FMU has been providing medical care forand 1,401 technical and administrative staff.

disaster victims that suffered from the GreatFMU Hospital serves as a general hospital

East Japan Earthquake and subsequentwith 36 clinical departments and 778 beds,

tsunami that ravaged the Tohoku region

offering advanced medical care. The

including Fukushima Prefecture, and serving as

average number of inpatients anda secondary radiation emergency medical care

outpatients per day were 591 and 1,455 infacility.

2013.
FMU’s mission is to protect and manage thehealth of people for generations to come.

Fukushima Medical University

113

114

PARTNERSPARTNERSPARTNERS / SUPPORTERS

ORGANIZERSGOVERNMENT SUPPORTMinistry of Health Labour and Welfare

115

116

SPEAKER INDEX WITH PICTURES

SPEAKER INDEX WITH PICTURES

Aida,
Jun

Asano,
Atsuyuki

Atun,
Rifat

Ayanian,John Z.

Bloom,
Barry R.

Canny,
Ben

Chien,
Kuo-Liong

Coresh,Josef

Krieger,
Eduardo

Kurokawa,
Kiyoshi

Kusaba,Tesshu

Kwon,
Soonman

Lee,
Kheng HockMaruyama,
Izumi

McNeil,John

Minato,Nagahiro

Coutinho,
Alex G.

Erdener,
Ugur

Flahault,
AntoineFukuhara,
ShunichiFukuyama,
HidenaoGanten,Detlev

Gauvin,
Lise

Goto,
Rei

Miyata,ToshioMori,
MasashiMorita,Akira

Munakata,
Mitsuru

Murofushi,
Koji

Nagayama,
Osamu

Nakayama,
Takeo

Nishimura,
Shuzo

Hashimoto,
Hideki

Hashimoto,
Shigeatsu

Hikichi,
HiroyukiHolm,Jens, V.

Howe,
AmandaImanaka,
YuichiImura,
Hiroo

Inui,
Thomas S.

Ohto,
Hitoshi

Omori,
Koichi

Piot,
Peter

Sanada,HisashiSankai,
Yoshiyuki

Shi,
Leiyu

Shirai,KokoroSlingsby,BT

Kaneda,Koichi

Kawachi,
IchiroKawakami,
Koji

Kikuchi,Shin-ichi

Kimura,ShinyaKinoshita,
Hiroo

Klag,
Michael J.

Kondo,
Katsunori

Takahashi,
MasayoTanner,Adam

Toumi,
Mondher

Uemoto,Shinji

Yasumura,
Seiji

Zalcberg,
John

117

118

SPEAKER LISTSPEAKER LIST

A

H

L

P

Aida, Jun ............................................ 054, 092

Hashimoto, Hideki ......................... 052, 090

Lee, Kheng Hock ............................. 034, 072

Piot, Peter ..................... 030, 032, 068, 070

Asano, Atsuyuki .............................. 044, 082

Hashimoto, Shigeatsu ................... 056, 094

Atun, Rifat ......................................... 056, 094

Hikichi, Hiroyuki .............................. 054, 092

Ayanian, John Z. ............................. 036, 074

Holm, Jens, V. .................................. 044, 082

MS

Howe, Amanda ............................... 034, 072

Maruyama, Izumi ............................ 034, 072

Sanada, Hisashi ............................... 044, 082

McNeil, John .................................... 040, 078

Sankai, Yoshiyuki ........................... 050, 088

Minato, Nagahiro ....... 026, 028, 064, 066

Shi, Leiyu ........................................... 034, 072

B
Bloom, Barry R. ............................... 028, 066

CI

Miyata, Toshio ................................. 030, 068

Shirai, Kokoro .................................. 054, 092

Imanaka, Yuichi .............................. 040, 078

Mori, Masashi ................................... 038, 076

Slingsby, BT ...................................... 032, 070

Imura, Hiroo ................. 058, 060, 096, 098

Morita, Akira .................................... 046, 084

Inui, Thomas S. ..................... 034, 048, 060

Munakata, Mitsuru .......................... 056, 094

072, 086, 098

Murofushi, Koji ................................ 044, 082

Canny, Ben ................... 048, 060, 086, 098
Chien, Kuo-Liong ........................... 040, 078
Coresh, Josef ................................... 048, 086
Coutinho, Alex G. ........................... 032, 070

E

Erdener, Ugur .............. 044, 060, 082, 098

TTakahashi, Masayo ......................... 058, 096

K

N

Kaneda, Koichi ............................... 032, 070

Nagayama, Osamu ........................ 032, 070

Kawachi, Ichiro ............ 052,054, 090, 092

Nakayama, Takeo .......................... 040, 078

Kawakami, Koji ............................... 046, 084

Nishimura, Shuzo ............................ 038, 076

Toumi, Mondher ............................. 046, 084

U
Uemoto, Shinji ................................ 026, 064

Kikuchi, Shin-ichi ............................ 026, 064
Kimura, Shinya ............................... 040, 078

Tanner, Adam ................................. 040, 078

Kinoshita, Hiroo ............................... 038, 076

O

Klag, Michael J. ............................... 026, 064

Ohto, Hitoshi .................................... 056, 094

Y

Flahault, Antoine ............................ 048, 086

Kondo, Katsunori ........................... 054, 092

Omori, Koichi .................................. 056, 094

Yasumura, Seiji ............................... 056, 094

Fukuhara, Shunichi .... 026, 036, 048, 060

Krieger, Eduardo ............................ 060, 098

064, 074, 086, 098

Kurokawa, Kiyoshi ......................... 032, 070

Fukuyama, Hidenao ....................... 038, 076

Kusaba, Tesshu ............................... 034, 072

Z

Kwon, Soonman .............................. 038, 076

Zalcberg, John ............................... 046, 084

FG

Ganten, Detlev ............ 026, 060, 064, 098
Gauvin, Lise ...................................... 050, 088
Goto, Rei ............................................ 038, 076

119

120

Sumiya

NOTES

121

122

NOTES

NOTES

123

124

NOTES

NOTES

125

126

NOTES

SAVE THE DATE127

SAVE THE DATE !
WORLD HEALTH SUMMITBERLIN, GERMANYOCTOBER 11-13, 2015

www.worldhealthsummit.org